These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35385768)
21. Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules. Park SJ; Jun YJ; Lee KJ; Hwang SM; Kim TH; Lee SH; Lee SH Am J Rhinol Allergy; 2014; 28(3):199-207. PubMed ID: 24980231 [TBL] [Abstract][Full Text] [Related]
22. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq. Kim J; Keys JR; Eckhart AD Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475 [TBL] [Abstract][Full Text] [Related]
24. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays. Willier S; Butt E; Grunewald TG Biol Cell; 2013 Aug; 105(8):317-33. PubMed ID: 23611148 [TBL] [Abstract][Full Text] [Related]
25. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature. Schleicher SM; Thotala DK; Linkous AG; Hu R; Leahy KM; Yazlovitskaya EM; Hallahan DE PLoS One; 2011; 6(7):e22182. PubMed ID: 21799791 [TBL] [Abstract][Full Text] [Related]
26. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636 [TBL] [Abstract][Full Text] [Related]
27. LPA Hao F; Liu Q; Zhang F; Du J; Dumire A; Xu X; Cui MZ J Biol Chem; 2021 Oct; 297(4):101152. PubMed ID: 34478715 [TBL] [Abstract][Full Text] [Related]
28. LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer. Zhao P; Yun Q; Li A; Li R; Yan Y; Wang Y; Sun H; Damirin A Med Oncol; 2022 Jan; 39(2):17. PubMed ID: 34982278 [TBL] [Abstract][Full Text] [Related]
29. CREB-dependent LPA-induced signaling initiates a pro-fibrotic feedback loop between small airway basal cells and fibroblasts. Nathan S; Zhang H; Andreoli M; Leopold PL; Crystal RG Respir Res; 2021 Apr; 22(1):97. PubMed ID: 33794877 [TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidic Acid and IL-6 Trans-signaling Interact via YAP/TAZ and STAT3 Signaling Pathways in Human Trabecular Meshwork Cells. Yemanyi F; Raghunathan V Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):29. PubMed ID: 33216119 [TBL] [Abstract][Full Text] [Related]
32. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy. Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961 [TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidic Acid Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased in Obesity. Fayyaz S; Japtok L; Schumacher F; Wigger D; Schulz TJ; Haubold K; Gulbins E; Völler H; Kleuser B Cell Physiol Biochem; 2017; 43(2):445-456. PubMed ID: 28922661 [TBL] [Abstract][Full Text] [Related]
34. Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism. D'Souza K; Nzirorera C; Cowie AM; Varghese GP; Trivedi P; Eichmann TO; Biswas D; Touaibia M; Morris AJ; Aidinis V; Kane DA; Pulinilkunnil T; Kienesberger PC J Lipid Res; 2018 Oct; 59(10):1805-1817. PubMed ID: 30072447 [TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase. Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641 [TBL] [Abstract][Full Text] [Related]
36. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts. Olianas MC; Dedoni S; Onali P Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927 [TBL] [Abstract][Full Text] [Related]
38. Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for Alveolarization. Funke M; Knudsen L; Lagares D; Ebener S; Probst CK; Fontaine BA; Franklin A; Kellner M; Kühnel M; Matthieu S; Grothausmann R; Chun J; Roberts JD; Ochs M; Tager AM Am J Respir Cell Mol Biol; 2016 Jul; 55(1):105-16. PubMed ID: 27082727 [TBL] [Abstract][Full Text] [Related]
39. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Park SY; Jeong KJ; Panupinthu N; Yu S; Lee J; Han JW; Kim JM; Lee JS; Kang J; Park CG; Mills GB; Lee HY Oncogene; 2011 Mar; 30(11):1351-9. PubMed ID: 21102517 [TBL] [Abstract][Full Text] [Related]
40. Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade. Miyabe Y; Miyabe C; Iwai Y; Yokoyama W; Sekine C; Sugimoto K; Harigai M; Miyasaka M; Miyasaka N; Nanki T Arthritis Res Ther; 2014 Oct; 16(5):461. PubMed ID: 25273676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]